Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

John Van Den Anker, MD, PhD, FCP, FAAP

Chief, Division of Clinical Pharmacology
Children's National Hosp

Dr. John van den Anker is a Professor of Pediatrics, Pharmacology, Physiology, Genomics and Precision Medicine at the George Washington University School of Medicine and Health Sciences, Washington, DC and holds the Evan and Cindy Jones Endowed Chair in Pediatric Clinical Pharmacology. He also is the Newton-Abraham Visiting Professor of Medical, Chemical, and Biological Sciences at the University of Oxford, United Kingdom.
Dr. van den Anker has been the President of the American College of Clinical Pharmacology (2016-2018) and twice the President of the European Society of Developmental, Perinatal and Pediatric Pharmacology (2006-2008 and 2017-2019). His awards include the Distinguished Investigator Award from the American College of Clinical Pharmacology (2008), the Distinguished Researcher award of the George Washington University (2012), and the Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics (2019) from the Pediatric Pharmacy Association.
Dr. van den Anker has recently become the Editor-in-Chief of the Journal of Clinical Pharmacology.
His research has focused on developmental, neonatal, and pediatric pharmacology. He has authored over 600 peer reviewed publications and has received NIH funding as well as funding from the European Union to support his research and the development of training programs in Pediatric Clinical Pharmacology.

Disclosure information not submitted.

Presentation(s):